Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: Long-term outcomes of a phase I-II trial. (2022). Radiology and Oncology, 56(2), 216-227. https://www.radioloncol.com/index.php/ro/article/view/3744